RxDoctor Payments Data

Guru Mohanty, MD

Clinical Cardiac Electrophysiology · North Chesterfield, VANPI 1699952275

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,799 of the $14,949 with a category attached, or 65.6%. 33 manufacturers reported payments, led by Abbott at 36.8% of the total. 2025 is the largest year on record at $4,388, 5.1 times the $853 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in VA, where the typical reported total is $19,771.

$14,949in general payments, 2019–2025

Across 280 payments — averaging $53.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Medtronic$3K
  • Boston Scientific$3K
  • Biosense Webster, Inc.$761
  • Impulse Dynamics (USA) Inc.$621
  • Johnson & Johnson$508
  • plus $2K from 27 others
$188,511in research payments, 2019–2025

Across 61 payments — averaging $3090.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$152K
  • Impulse Dynamics (USA) Inc.$37K

What the payments were for

  • Consulting fees$5254%
  • Travel & lodging$4,14428%
  • Food & beverage$9,79966%
  • Education$4813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,949 in reported general payments places this provider in the 40th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia

Medicare billing

Part B allowed, 2024
$758,502
Medicare patients
1,217
Services billed
8,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban373$317,042
XareltoRivaroxaban181$190,238
EntrestoSacubitril/Valsartan68$69,990
JardianceEmpagliflozin13$10,306
Dofetilide29$9,724
Amiodarone Hcl58$2,632
Flecainide Acetate96$2,490
Metoprolol Succinate226$2,360
Diltiazem 24hr Er (Cd)Diltiazem Hcl85$2,220
SotalolSotalol Hcl44$659
ClopidogrelClopidogrel Bisulfate45$601
Lisinopril80$586
Diltiazem 24hr ErDiltiazem Hcl13$549
Carvedilol52$487
Amlodipine Besylate87$401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$173$317,042373 claims
Johnson & JohnsonXarelto$508$190,238181 claims
NovartisEntresto$390$69,99068 claims
Boehringer IngelheimJardiance$132$10,30613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

Other clinical cardiac electrophysiology in North Chesterfield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →